TheraRadar
← Back
Data updated: Mar 29, 2026

KING PHARMS LLC

Infectious DiseaseDermatologyOncology
Big Pharma

KING PHARMS LLC is a major pharmaceutical company focused on Infectious Disease, Dermatology, Oncology.

1948
Since
25
Drugs
-
Trials
11
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PENICILLIN G PROCAINE 2025-08-26
Labeling
PENICILLIN G PROCAINE 2025-08-26
Labeling
PENICILLIN G PROCAINE 2025-08-26
Labeling
QUINIDINE SULFATE 2025-08-21
Labeling
QUINIDINE SULFATE 2025-07-29
Labeling
SKELAXIN 2024-06-21
Labeling
TAPAZOLE 2024-06-14
Labeling
PENICILLIN G PROCAINE 2024-06-07
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 25%
2 drugs
Dermatology 25%
2 drugs
Oncology 25%
2 drugs
Metabolic 25%
2 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Merck big-pharma
Oncology, Infectious Disease, Metabolic
Baxter specialty
Infectious Disease, Oncology, Dermatology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease